In an average pregnancy, 13% of the free DNA in the peripheral circulation of the mother originates from the fetus. This is sufficient that non-invasive detection of fetal aneuploidies by DNA sequencing will soon become routine. It is also possible to reconstruct most of the fetal genome sequence by sampling the DNA in the mothers blood, but this is still too costly for routine use. The methods developed to analyze these mixed maternal fetal DNA samples should be applicable to other problems in DNA mixture sequencing.
The presentation will cover:
Plasma DNA as a biomarker
Estimation of the fraction of fetal DNA in maternal plasma
Non-invasive prenatal detection of trisomy 21
Non-invasive whole genome sequencing on an unborn fetus
Sequenom, Inc. designs, develops, manufactures and markets innovative technology, instrumentation and tests that target and serve discovery and clinical research, and clinical molecular diagnostics markets. Applications include translational research, oncology, agricultural genomics and in vitro diagnostics for prenatal and retinal disorders.
August 6-8, 2012 · San Francisco, CA
A new paradigm in drug and diagnostic development is emerging. Exciting scientific discoveries in genome biology and technology are paving the way to new product development and commercial opportunities for Rx, Dx and technology platform companies. Join us in San Francisco this August for IBC's all new Drug & Diagnostic Development event - featuring these 4 compelling conferences:
Presenter: Dr. Charles Cantor, Chief Scientific Officer, Sequenom, Inc.
Dr. Charles R. Cantor, Ph.D. is the Founder of Sequenom Inc. and has been its Chief Scientific Officer since August 1998. Dr. Cantor is a Consultant to more than 16 biotech firms. From 1992 to August 1998, Dr. Cantor served as the Chairman and a Professor in the Department of Biomedical Engineering and Director of the Center for Advanced Biotechnology at Boston University.
Noninvasive Sequencing of Fetal DNA
Tuesday, May 22, 2012
2:00 pm (EDT)
3:00 pm (EDT)
After registering you will receive a confirmation email containing information about joining the Webinar.
Required: Windows® 7, Vista, XP or 2003 Server
Mac OS® X 10.5 or newer
Copyright IBC Life Sciences, a part of Informa Life Sciences Group.Phone: 800.390.4078Email: email@example.com